Lipoxin A4 modifies platelet-derived growth factor-induced pro-fibrotic gene expression in human renal mesangial cells.
about
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) familyNew endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseasesSpecialized pro-resolving lipid mediators in the inflammatory response: An updateMolecular biology for formyl peptide receptors in human diseases.Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins.Lipoxin A(4) regulates bronchial epithelial cell responses to acid injury.Lipoxin A4 Attenuates Constitutive and TGF-β1-Dependent Profibrotic Activity in Human Lung MyofibroblastsMechanisms of Disease: leukotrienes and lipoxins in scleroderma lung disease--insights and potential therapeutic implications.Lipoxins attenuate renal fibrosis by inducing let-7c and suppressing TGFβR1.D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injuryOsteitis fibrosa is mediated by Platelet-Derived Growth Factor-A via a phosphoinositide 3-kinase-dependent signaling pathway in a rat model for chronic hyperparathyroidism.Lipoxins: resolutionary road.Effects of polyunsaturated fatty acid consumption in diabetic nephropathy.Lipoxin A4 Attenuates Bronchopulmonary Dysplasia via Upregulation of Let-7c and Downregulation of TGF-β1 Signaling Pathway.Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF-kappaB and snailC-type natriuretic peptide suppresses mesangial proliferation and matrix expression via a MMPs/TIMPs-independent pathway in vitro.
P2860
Q24652940-70FE6808-6657-4B25-BAFB-032474CDD94FQ28222356-98F6ABC0-31B4-4BC7-BC3D-3B735C5D838BQ33657562-F7ABF35F-64B7-42A4-9065-28F61FB80349Q34327503-600DEC40-1E95-4517-9F80-0C9AF21EE990Q34522097-C06A8F13-301A-403D-BC85-1E1557B72299Q35088140-72D30BC9-C397-421B-897B-11D8C0F6955FQ36029120-9C2A39E7-7B80-45E1-987B-F87229E0961FQ36699060-A51A96E3-D6C2-44DE-935D-C8ADB03FAB60Q36719241-1B33D23C-F9E3-4500-85E4-EA6181350BF0Q36860274-B475C799-0A20-4A26-A33A-1AFCE7438BA3Q36976360-F4F323F3-AA7B-48D8-A526-A347F9E49815Q37604436-8EECB2CF-8494-478E-888B-554FD817EC60Q37816963-0AA2204E-26B7-45EE-9EC9-0C09B21F6547Q42513809-1CB5D42D-B230-40B0-870B-B0524F4AC202Q42738098-EC29F5A1-26D4-46B2-BFC9-E47DF9874750Q50616926-AB459F22-565A-414C-A953-678576E7E0D8
P2860
Lipoxin A4 modifies platelet-derived growth factor-induced pro-fibrotic gene expression in human renal mesangial cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Lipoxin A4 modifies platelet-d ...... n human renal mesangial cells.
@en
type
label
Lipoxin A4 modifies platelet-d ...... n human renal mesangial cells.
@en
prefLabel
Lipoxin A4 modifies platelet-d ...... n human renal mesangial cells.
@en
P2093
P2860
P1476
Lipoxin A4 modifies platelet-d ...... n human renal mesangial cells.
@en
P2093
Blaithin McMahon
Catherine Godson
Denise Sadlier
Derick Mitchell
Karen Rodgers
P2860
P304
P356
10.1016/S0002-9440(10)62043-3
P407
P577
2005-09-01T00:00:00Z